• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

输血治疗建议。容量替代、提高氧运输能力及凝血因子替代(作者译)

[Recommendations for transfusion therapy. Volume substitution, raising oxygen transport capacity and replacement of clotting factors (author's transl)].

作者信息

Abdulla W, Frey R, Witzke G

出版信息

MMW Munch Med Wochenschr. 1979 Aug 10;121(32-33):1051-4.

PMID:112468
Abstract

The principal aims of whole blood transfusion therapy are simultaneous volume substitution, raising the oxygen transport capacity and the replacement of clotting factors. The necessary control factors for volume substitution are described. It must be borne in mind that the blood undergoes changes during storage which among other things affects the ability of the blood to transport oxygen and the clotting potential. Not only the destruction of thrombocytes must be considered but also the loss of activity of the proaccelerin and the antihemophilic globulin A. For this reason for massive blood transfusions using older blood conserves it is recommended that the loss of activity be compensated by antihemophilic cryoprecipitate.

摘要

全血输血疗法的主要目的是同时进行容量替代、提高氧运输能力以及补充凝血因子。文中描述了容量替代所需的控制因素。必须牢记,血液在储存过程中会发生变化,这在一定程度上会影响血液运输氧气的能力和凝血潜能。不仅要考虑血小板的破坏,还要考虑前加速素和抗血友病球蛋白A活性的丧失。因此,对于使用保存时间较长的血液进行大量输血的情况,建议用抗血友病冷沉淀来补偿活性的丧失。

相似文献

1
[Recommendations for transfusion therapy. Volume substitution, raising oxygen transport capacity and replacement of clotting factors (author's transl)].输血治疗建议。容量替代、提高氧运输能力及凝血因子替代(作者译)
MMW Munch Med Wochenschr. 1979 Aug 10;121(32-33):1051-4.
2
[Coagulation problems associated with massive blood transfusions. An experimental study (author's transl)].[大量输血相关的凝血问题。一项实验研究(作者译)]
Anaesthesist. 1979 Jul;28(7):322-7.
3
Clinical use of blood, blood components and blood products.血液、血液成分及血液制品的临床应用。
Can Med Assoc J. 1979 Jul 7;121(1):33-42.
4
[Antihemophilic activity of donor blood].[供血者血液的抗血友病活性]
Probl Gematol Pereliv Krovi. 1976;21(9):45-6.
5
[Blood transfusions for intraoperative hemorrhage].术中出血的输血治疗
Intensivmed Prax. 1980(2):79-82.
6
[Blood component therapy: differential indication for erythrocyte transfusion].[血液成分疗法:红细胞输血的不同适应证]
Infusionsther Klin Ernahr. 1980 Aug;7(4):184-9.
7
[Influence of the massive transfusion of cold and warmed preserved blood on the oxygen-transport function of the blood].[大量输注冷藏和温热保存血液对血液氧运输功能的影响]
Zentralbl Chir. 1975;100(22):1364-71.
8
[The oxygen transport function of the blood and of the erythrocyte concentrate during storage and its importance for blood transfusion].[储存期间血液及红细胞浓缩物的氧运输功能及其对输血的重要性]
Folia Haematol Int Mag Klin Morphol Blutforsch. 1984;111(3):360-9.
9
The influence of altered blood volume and oxygen transport capacity on aerobic performance.血容量和氧运输能力改变对有氧运动能力的影响。
Exerc Sport Sci Rev. 1985;13:75-93.
10
Preparation and testing of antihemophilic globulin (Factor 8) sources for transfusion therapy in hemophilia. Description of a new sterile concentrate process for blood banks.用于血友病输血治疗的抗血友病球蛋白(因子VIII)来源的制备与检测。血库一种新型无菌浓缩工艺的描述。
Scand J Clin Lab Invest. 1965;17:Suppl 84:70-7.